Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiencyIgnacio García‐Tuñón(Universidad de Salamanca), Manuel Sánchez‐Martín(Universidad de Salamanca)PLoS ONEMay 9, 201910.1371/journal.pone.0216674Cited by 29SaveCiteExport RISWatch citationsRelated PapersThe CRISPR/Cas9 system efficiently reverts the tumorigenic ability of <i>BCR/ABL in vitro</i> and in a xenograft model of chronic myeloid leukemia|Oncotarget|2017|40